Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Distinct endothelial cell toxicities of Abl tyrosine kinase inhibitors lead to arterial thrombosis

Blood Vessels Thrombosis & Hemostasis(2025)10.1016/j.bvth.2025.100127Source: DataRank Database

Distinct endothelial cell toxicities of Abl tyrosine kinase inhibitors lead to arterial thrombosis is a research paper published in Blood Vessels Thrombosis & Hemostasis (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.58)OA: goldTopics (12)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Alec Stepanian ORCID,Sebastiana Redford,Gregory Martin,Nicole L. Svedberg,Kun Xu

Live enrichment

PubMed:41573101 OpenAlex:https://openalex.org/W7106104522

American Heart Association

Grant: NHLBI HL167383

American Heart Association

Grant: F30HL175876

American Heart Association

Grant: F30HL170641

NCATS

Grant: 1K12TR004384

National Heart Lung and Blood Institute

Grant: F32HL165838

National Heart Lung and Blood Institute

Grant: HL155078

American Heart Association-American Stroke Association

Grant: 25PRE1374117

American Heart Association-American Stroke Association

Grant: 24PRE1195465

NCATS NIH HHS

Grant: K12 TR004384

NHLBI NIH HHS

Grant: R01 HL167383

NHLBI NIH HHS

Grant: R01 HL155078

FWCI

1.58

Citation Percentile

0.9%

Citation Trend

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.bvth.2025.100127

publisherhttps://doi.org/10.1016/j.bvth.2025.100127

publisherhttps://api.elsevier.com/content/article/PII:S2950327225000841?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2950327225000841?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41573101

Fields of Study

Chronic Myeloid Leukemia TreatmentsChemotherapy-induced cardiotoxicity and mitigationAntiplatelet Therapy and Cardiovascular Diseases

Keywords

NilotinibDasatinibPonatinibTyrosine kinaseTyrosine-kinase inhibitorBosutinibEndothelial stem cellPlateletImatinib

Sustainable Development Goals

SDG 0: Good health and well-being